We provide evidence in this study showing that this process also exists in ovarian cancer cells, and is controlled by the expression level of DDB2, e.g., high levels of DDB2 in ovarian cancer cells inhibit their capacity of dedifferentiation, halting the replenishment of CSCs, and hindering the ovarian cancer progression. The gene discussed is DDB2; the disease is ovarian carcinoma.